 Matthew Witkowski
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2026 | 89 | 3.800 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2026 | 293 | 2.420 |
Why?
| | Lymphoma, B-Cell | 2 | 2023 | 134 | 1.390 |
Why?
| | Immunotherapy, Adoptive | 5 | 2026 | 339 | 1.280 |
Why?
| | Tumor Microenvironment | 6 | 2023 | 729 | 1.120 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2025 | 685 | 1.010 |
Why?
| | Leukemia | 4 | 2025 | 245 | 0.990 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2026 | 881 | 0.990 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2026 | 22 | 0.970 |
Why?
| | Ikaros Transcription Factor | 2 | 2017 | 23 | 0.930 |
Why?
| | Bone Marrow | 4 | 2022 | 306 | 0.860 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2025 | 26 | 0.820 |
Why?
| | Lipid Metabolism | 1 | 2026 | 524 | 0.740 |
Why?
| | Burkitt Lymphoma | 1 | 2022 | 62 | 0.710 |
Why?
| | Monocytes | 2 | 2023 | 536 | 0.670 |
Why?
| | Immunity | 1 | 2019 | 139 | 0.570 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 201 | 0.500 |
Why?
| | Chromatin Assembly and Disassembly | 3 | 2026 | 108 | 0.460 |
Why?
| | Immunotherapy | 2 | 2022 | 662 | 0.450 |
Why?
| | Receptors, Notch | 2 | 2019 | 90 | 0.450 |
Why?
| | F-Box Proteins | 1 | 2015 | 23 | 0.430 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1145 | 0.390 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 191 | 0.390 |
Why?
| | T-Lymphocytes | 5 | 2025 | 1984 | 0.390 |
Why?
| | Cell Line, Tumor | 7 | 2026 | 3523 | 0.340 |
Why?
| | Stem Cell Niche | 3 | 2020 | 57 | 0.330 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 628 | 0.330 |
Why?
| | Animals | 17 | 2026 | 37948 | 0.320 |
Why?
| | Single-Cell Analysis | 4 | 2025 | 357 | 0.320 |
Why?
| | Molecular Targeted Therapy | 2 | 2026 | 437 | 0.310 |
Why?
| | Mice | 14 | 2026 | 18261 | 0.310 |
Why?
| | B-Lymphocytes | 3 | 2026 | 875 | 0.300 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2026 | 925 | 0.280 |
Why?
| | Trans-Activators | 2 | 2022 | 397 | 0.280 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1319 | 0.260 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 971 | 0.260 |
Why?
| | Lab-On-A-Chip Devices | 2 | 2025 | 60 | 0.250 |
Why?
| | Mutation | 4 | 2025 | 4081 | 0.250 |
Why?
| | Humans | 29 | 2026 | 144667 | 0.250 |
Why?
| | Flow Cytometry | 2 | 2023 | 1154 | 0.230 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2025 | 28 | 0.230 |
Why?
| | Hematopoietic Stem Cells | 2 | 2019 | 419 | 0.230 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2025 | 70 | 0.230 |
Why?
| | Cell Lineage | 2 | 2025 | 376 | 0.230 |
Why?
| | Multipotent Stem Cells | 1 | 2025 | 21 | 0.230 |
Why?
| | Bioengineering | 1 | 2025 | 20 | 0.220 |
Why?
| | Cell Differentiation | 5 | 2026 | 2037 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.220 |
Why?
| | Antigens, CD19 | 2 | 2022 | 129 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 2 | 2019 | 619 | 0.220 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.220 |
Why?
| | Diphtheria Toxin | 1 | 2025 | 65 | 0.220 |
Why?
| | Immunotoxins | 1 | 2025 | 55 | 0.210 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 111 | 0.210 |
Why?
| | Lymphopoiesis | 1 | 2024 | 27 | 0.210 |
Why?
| | Clonal Evolution | 1 | 2024 | 47 | 0.200 |
Why?
| | Chromatin | 2 | 2024 | 554 | 0.190 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2022 | 10 | 0.190 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2201 | 0.190 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2023 | 129 | 0.180 |
Why?
| | Polyadenylation | 1 | 2022 | 41 | 0.180 |
Why?
| | Phospholipase C gamma | 1 | 2022 | 28 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2026 | 532 | 0.180 |
Why?
| | Valine-tRNA Ligase | 1 | 2021 | 1 | 0.180 |
Why?
| | Osteoblasts | 2 | 2020 | 146 | 0.180 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2024 | 337 | 0.180 |
Why?
| | Valine | 1 | 2021 | 80 | 0.170 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.170 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 76 | 0.170 |
Why?
| | Mitochondria | 2 | 2025 | 984 | 0.170 |
Why?
| | Adipocytes | 2 | 2020 | 223 | 0.170 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 163 | 0.170 |
Why?
| | Antigens, Surface | 1 | 2021 | 155 | 0.160 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 496 | 0.150 |
Why?
| | Cell Transdifferentiation | 1 | 2019 | 31 | 0.150 |
Why?
| | Bone Marrow Transplantation | 1 | 2020 | 293 | 0.140 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 93 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2019 | 342 | 0.130 |
Why?
| | Signal Transduction | 4 | 2022 | 5185 | 0.130 |
Why?
| | Catenins | 1 | 2017 | 6 | 0.130 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2017 | 68 | 0.120 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 14 | 0.120 |
Why?
| | bcl-X Protein | 1 | 2016 | 45 | 0.120 |
Why?
| | Endothelium, Vascular | 2 | 2020 | 949 | 0.120 |
Why?
| | Vitamins | 1 | 2017 | 176 | 0.120 |
Why?
| | Ascorbic Acid | 1 | 2017 | 171 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 667 | 0.110 |
Why?
| | Myelodysplastic Syndromes | 1 | 2017 | 147 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2019 | 428 | 0.110 |
Why?
| | Proteome | 1 | 2020 | 515 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 407 | 0.110 |
Why?
| | F-Box-WD Repeat-Containing Protein 7 | 1 | 2015 | 6 | 0.110 |
Why?
| | Survival Rate | 1 | 2020 | 2089 | 0.110 |
Why?
| | Prognosis | 2 | 2023 | 4312 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2019 | 523 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2017 | 370 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 138 | 0.110 |
Why?
| | PAX5 Transcription Factor | 1 | 2014 | 14 | 0.110 |
Why?
| | RNA, Messenger | 1 | 2022 | 2815 | 0.100 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2014 | 41 | 0.100 |
Why?
| | Neoplasm Proteins | 1 | 2017 | 441 | 0.100 |
Why?
| | Apoptosis | 2 | 2025 | 2397 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 461 | 0.090 |
Why?
| | Blood Platelets | 1 | 2016 | 379 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2015 | 2184 | 0.090 |
Why?
| | Blotting, Western | 1 | 2015 | 1161 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2020 | 3603 | 0.090 |
Why?
| | Piperidines | 2 | 2025 | 219 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5967 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 552 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2017 | 1159 | 0.080 |
Why?
| | Recurrence | 2 | 2024 | 1136 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2017 | 1484 | 0.080 |
Why?
| | Child, Preschool | 2 | 2024 | 11790 | 0.070 |
Why?
| | Carcinogenesis | 2 | 2019 | 227 | 0.060 |
Why?
| | Child | 3 | 2024 | 22600 | 0.060 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2026 | 30 | 0.060 |
Why?
| | Transcriptome | 2 | 2025 | 1036 | 0.060 |
Why?
| | Female | 6 | 2025 | 78304 | 0.060 |
Why?
| | Infant | 1 | 2020 | 10023 | 0.060 |
Why?
| | Azetidines | 1 | 2025 | 45 | 0.060 |
Why?
| | Observational Studies as Topic | 1 | 2025 | 131 | 0.050 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 334 | 0.050 |
Why?
| | Adolescent | 2 | 2024 | 22409 | 0.050 |
Why?
| | Male | 5 | 2025 | 72431 | 0.050 |
Why?
| | Mice, SCID | 1 | 2025 | 368 | 0.050 |
Why?
| | Adult | 3 | 2025 | 40489 | 0.050 |
Why?
| | Translocation, Genetic | 1 | 2024 | 118 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2025 | 306 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2025 | 279 | 0.050 |
Why?
| | Young Adult | 1 | 2020 | 14122 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2025 | 610 | 0.050 |
Why?
| | Clinical Decision-Making | 1 | 2026 | 360 | 0.050 |
Why?
| | Oncogenes | 1 | 2023 | 118 | 0.050 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2021 | 17 | 0.040 |
Why?
| | Precision Medicine | 1 | 2026 | 454 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2020 | 17149 | 0.040 |
Why?
| | Electron Transport Complex I | 1 | 2021 | 42 | 0.040 |
Why?
| | Biological Availability | 1 | 2021 | 143 | 0.040 |
Why?
| | Sulfonamides | 1 | 2025 | 579 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 133 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 372 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 379 | 0.040 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 35 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2021 | 144 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 209 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 238 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 167 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2022 | 394 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1029 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2591 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 442 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2019 | 4110 | 0.040 |
Why?
| | Adenine | 1 | 2022 | 337 | 0.040 |
Why?
| | Cell Plasticity | 1 | 2019 | 37 | 0.040 |
Why?
| | Receptors, Interferon | 1 | 2019 | 60 | 0.040 |
Why?
| | Tretinoin | 1 | 2019 | 124 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2019 | 146 | 0.030 |
Why?
| | Pyrazoles | 1 | 2022 | 512 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 222 | 0.030 |
Why?
| | Dioxygenases | 1 | 2017 | 36 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2017 | 169 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 246 | 0.030 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 53 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2019 | 319 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 426 | 0.030 |
Why?
| | Cell Death | 1 | 2017 | 382 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2019 | 451 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1726 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 313 | 0.030 |
Why?
| | Genes, myc | 1 | 2014 | 51 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 49 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1270 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 935 | 0.020 |
Why?
| | Risk Assessment | 1 | 2022 | 3729 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1092 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 664 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3109 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 35971 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2870 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1468 | 0.020 |
Why?
| | Cell Line | 1 | 2016 | 2821 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2243 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1437 | 0.020 |
Why?
|
|
Witkowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|